ClearPoint Neuro (CLPT) Invested Capital (2011 - 2026)

ClearPoint Neuro's Invested Capital history runs 16 years deep, the most recent figure standing at $18.8 million for Q1 2026.

• In Q1 2026, Invested Capital fell 5.73% year-over-year to $18.8 million; the TTM figure through Mar 2026 stood at $18.8 million (down 5.73% YoY), while the FY2025 annual figure was $28.0 million, up 10.36% from the prior year.
• Invested Capital came in at $18.8 million for Q1 2026 at ClearPoint Neuro, down from $28.0 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $55.6 million in Q1 2022 to a low of $15.9 million in Q3 2025.
• A 5-year average of $34.9 million and a median of $34.0 million in 2023 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital increased 26.37% in 2022 and slumped 55.13% in 2025, its largest moves.
• ClearPoint Neuro's Invested Capital stood at $46.8 million in 2022, then plunged by 33.36% to $31.2 million in 2023, then declined by 18.55% to $25.4 million in 2024, then increased by 10.36% to $28.0 million in 2025, then sank by 32.76% to $18.8 million in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $18.8 million, $28.0 million, and $15.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison